|
|
|
Insider
Information: |
Mirviss Jeffrey B. |
Relationship: |
EVP&Pres, Periph Inter... |
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
58,098 |
|
Indirect Shares
|
25,000 |
|
|
Direct
Value |
$4,331,206 |
|
|
Indirect Value
|
$1,863,750 |
|
|
Total
Shares |
83,098 |
|
|
Total
Value |
$6,194,956 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
EVP&Pres, Periph Inter... |
2024-03-18 |
58,098 |
2020-09-03 |
25,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
222 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2022-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
649 |
111,288 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2022-12-09 |
4 |
OE |
$13.08 |
$387,155 |
D/D |
29,599 |
140,591 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2022-12-09 |
4 |
AS |
$46.15 |
$1,893,504 |
D/D |
(41,032) |
99,559 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2022-12-12 |
4 |
AS |
$46.75 |
$517,990 |
D/D |
(11,080) |
88,479 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,981 |
98,460 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-01-01 |
4 |
D |
$46.27 |
$149,452 |
D/D |
(3,230) |
95,230 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-01-04 |
4 |
AS |
$46.38 |
$313,123 |
D/D |
(6,751) |
88,479 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,031 |
90,510 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-15 |
4 |
D |
$47.29 |
$29,414 |
D/D |
(622) |
89,888 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,970 |
92,858 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-16 |
4 |
D |
$46.48 |
$42,250 |
D/D |
(909) |
91,949 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-16 |
4 |
AS |
$46.79 |
$65,927 |
D/D |
(1,409) |
90,540 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-17 |
4 |
AS |
$46.35 |
$95,527 |
D/D |
(2,061) |
90,792 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-17 |
4 |
D |
$46.54 |
$47,471 |
D/D |
(1,020) |
92,853 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,333 |
93,873 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,817 |
93,609 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-18 |
4 |
D |
$46.54 |
$46,633 |
D/D |
(1,002) |
92,607 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,804 |
95,411 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-21 |
4 |
D |
$46.23 |
$59,128 |
D/D |
(1,279) |
94,132 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-21 |
4 |
AS |
$46.32 |
$107,138 |
D/D |
(2,313) |
91,819 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-02-22 |
4 |
AS |
$46.10 |
$153,974 |
D/D |
(3,340) |
88,479 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-04-05 |
4 |
AS |
$50.40 |
$247,111 |
D/D |
(4,903) |
78,673 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-08-28 |
4 |
AS |
$53.14 |
$742,419 |
D/D |
(13,971) |
65,245 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-08-29 |
4 |
AS |
$54.50 |
$253,811 |
D/D |
(4,657) |
60,588 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP&Pres, Periph Intervent |
|
2023-11-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
56,588 |
0 |
- |
|
222 Records found
|
|
Page 8 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|